Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 44,300 shares, a growth of 6.7% from the January 15th total of 41,500 shares. Based on an average daily trading volume, of 124,500 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analyst Weigh In

Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a "strong-buy" rating in a report on Friday, October 25th.

Fresenius SE & Co. KGaA Price Performance

Shares of FSNUY stock traded down $0.05 on Friday, reaching $9.58. 14,448 shares of the company's stock traded hands, compared to its average volume of 63,831. Fresenius SE & Co. KGaA has a 12-month low of $6.57 and a 12-month high of $10.15. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. The business's 50 day moving average price is $9.28 and its two-hundred day moving average price is $9.16.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.